Prepandemic influenza vaccine (H5N1) (surface antigen, inactivated, adjuvanted) Novartis Vaccines and Diagnostics Europäische Union - Deutsch - EMA (European Medicines Agency)

prepandemic influenza vaccine (h5n1) (surface antigen, inactivated, adjuvanted) novartis vaccines and diagnostics

novartis vaccines and diagnostics s.r.l. - influenza-virus-oberflächenantigene (hämagglutinin und neuraminidase) des stammes a / vietnam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - impfstoffe - aktive immunisierung gegen den h5n1-subtyp des influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Interface Suspensionskonzentrat Deutschland - Deutsch - BVL (Bundesamt für Verbraucherschutz und Lebensmittelsicherheit)

interface suspensionskonzentrat

bayer cropscience - suspensionskonzentrat - 256,4 g/kg iprodion; 16 g/kg trifloxystrobin - fungizid

Sulfacet Deutschland - Deutsch - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

sulfacet

sanofi winthrop gmbh [hist] - trimethoprim, sulfamethoxazol - kapsel - trimethoprim 80.mg; sulfamethoxazol 400.mg